Aversion instead of preference learning indicated by nicotine place conditioning in rats. 1990

D E Jorenby, and R E Steinpreis, and J E Sherman, and T B Baker
Department of Psychology, University of Wisconsin-Madison 53706.

Although nicotine is a drug of abuse for millions of smokers, it has been difficult to demonstrate clearly the motivational properties of nicotine with rats using the conditioned place preference (CPP) paradigm. The first experiment attempted to replicate CPPs reported by other researchers using nicotine doses of 0.4, 0.8, and 1.2 mg/kg. There was a trend for all three doses to produce aversions, but it was significant only for the 0.8 mg/kg dose. Exposures to the CS alone extinguished aversions, but a "priming" dose (0.2 mg/kg) of nicotine given after extinction produced aversions only in animals exposed to 1.2 mg/kg. Experiment 2 tested whether preexposure to morphine or nicotine would sensitize animals to nicotine's reinforcing effects. In this experiment, rats were exposed to either six nicotine (0.6 mg/kg) or morphine (1.0 mg/kg) dosings prior to preference conditioning. Neither preferences nor aversions were observed in any group following subsequent conditioning with 0.6 mg/kg nicotine. The results suggest that previous observations of preference effects may have been due to specific procedural factors or may have depended on negative reinforcement due to stress reduction.

UI MeSH Term Description Entries
D009020 Morphine The principal alkaloid in opium and the prototype opiate analgesic and narcotic. Morphine has widespread effects in the central nervous system and on smooth muscle. Morphine Sulfate,Duramorph,MS Contin,Morphia,Morphine Chloride,Morphine Sulfate (2:1), Anhydrous,Morphine Sulfate (2:1), Pentahydrate,Oramorph SR,SDZ 202-250,SDZ202-250,Chloride, Morphine,Contin, MS,SDZ 202 250,SDZ 202250,SDZ202 250,SDZ202250,Sulfate, Morphine
D009538 Nicotine Nicotine is highly toxic alkaloid. It is the prototypical agonist at nicotinic cholinergic receptors where it dramatically stimulates neurons and ultimately blocks synaptic transmission. Nicotine is also important medically because of its presence in tobacco smoke. Nicotine Bitartrate,Nicotine Tartrate
D003216 Conditioning, Operant Learning situations in which the sequence responses of the subject are instrumental in producing reinforcement. When the correct response occurs, which involves the selection from among a repertoire of responses, the subject is immediately reinforced. Instrumental Learning,Learning, Instrumental,Operant Conditioning,Conditionings, Operant,Instrumental Learnings,Learnings, Instrumental,Operant Conditionings
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001362 Avoidance Learning A response to a cue that is instrumental in avoiding a noxious experience. Aversion Behavior,Aversion Learning,Aversive Behavior,Aversive Learning,Avoidance Behavior,Aversion Behaviors,Aversive Behaviors,Avoidance Behaviors,Behavior, Aversion,Behavior, Aversive,Behavior, Avoidance,Behaviors, Aversion,Behaviors, Aversive,Behaviors, Avoidance,Learning, Aversion,Learning, Aversive,Learning, Avoidance
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

D E Jorenby, and R E Steinpreis, and J E Sherman, and T B Baker
January 1992, Journal of psychopharmacology (Oxford, England),
D E Jorenby, and R E Steinpreis, and J E Sherman, and T B Baker
January 1987, Psychopharmacology,
D E Jorenby, and R E Steinpreis, and J E Sherman, and T B Baker
January 1995, Pharmacology, biochemistry, and behavior,
D E Jorenby, and R E Steinpreis, and J E Sherman, and T B Baker
December 2013, Learning & behavior,
D E Jorenby, and R E Steinpreis, and J E Sherman, and T B Baker
January 2014, Journal of Nippon Medical School = Nippon Ika Daigaku zasshi,
D E Jorenby, and R E Steinpreis, and J E Sherman, and T B Baker
September 1994, Progress in neuro-psychopharmacology & biological psychiatry,
D E Jorenby, and R E Steinpreis, and J E Sherman, and T B Baker
December 1996, European journal of pharmacology,
D E Jorenby, and R E Steinpreis, and J E Sherman, and T B Baker
September 2011, Pharmacology, biochemistry, and behavior,
D E Jorenby, and R E Steinpreis, and J E Sherman, and T B Baker
September 2008, Behavioural processes,
D E Jorenby, and R E Steinpreis, and J E Sherman, and T B Baker
April 2000, Neuroreport,
Copied contents to your clipboard!